ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 214 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,007,000 | -80.3% | 71,500 | -57.9% | 0.56% | -42.0% |
| Q4 2017 | $5,119,000 | -43.4% | 170,000 | -29.2% | 0.97% | -40.3% |
| Q3 2017 | $9,041,000 | +29.7% | 240,000 | -4.0% | 1.62% | -16.9% |
| Q2 2017 | $6,973,000 | -74.1% | 250,000 | -68.1% | 1.95% | -69.4% |
| Q1 2017 | $26,911,000 | +211.0% | 782,756 | +160.9% | 6.38% | +98.3% |
| Q4 2016 | $8,652,000 | +4.6% | 300,000 | +15.4% | 3.22% | +3.6% |
| Q3 2016 | $8,270,000 | +196.2% | 260,000 | +202.3% | 3.11% | +131.4% |
| Q2 2016 | $2,792,000 | – | 85,999 | – | 1.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |